Circulating tumor DNA analysis for tumor diagnosis.

Yi-Hui Wang1, Zhen Song1, Xin-Yuan Hu1

  • 1Key Laboratory of Drug Quality Control and Pharmacovigilance (Ministry of Education), China Pharmaceutical University, Nanjing, 210009, China; Department of Pharmaceutical Analysis, China Pharmaceutical University, Nanjing, 210009, China.

Talanta
|March 28, 2021
PubMed
Summary

Detecting circulating tumor DNA (ctDNA) mutations in blood offers a promising, less invasive method for early cancer diagnosis. Advanced techniques like digital PCR and Next Generation Sequencing are crucial for identifying these trace mutations.

Related Concept Videos